Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Global Eagle Acquisition Corp (ENT)

Page 1 of 2

Global Eagle Acquisition Corp (NASDAQ:ENT) has experienced an increase in enthusiasm from smart money lately.

In the 21st century investor’s toolkit, there are a multitude of methods shareholders can use to track the equity markets. A couple of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top investment managers can beat their index-focused peers by a solid margin (see just how much).


Equally as important, optimistic insider trading sentiment is a second way to break down the investments you’re interested in. As the old adage goes: there are many motivations for an upper level exec to get rid of shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Many academic studies have demonstrated the valuable potential of this tactic if shareholders understand what to do (learn more here).

With these “truths” under our belt, it’s important to take a peek at the key action regarding Global Eagle Acquisition Corp (NASDAQ:ENT).

What does the smart money think about Global Eagle Acquisition Corp (NASDAQ:ENT)?

In preparation for this year, a total of 11 of the hedge funds we track were long in this stock, a change of 10% from one quarter earlier. With hedge funds’ sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings meaningfully.

When looking at the hedgies we track, AQR Capital Management, managed by Cliff Asness, holds the largest position in Global Eagle Acquisition Corp (NASDAQ:ENT). AQR Capital Management has a $16.7 million position in the stock, comprising 0.1% of its 13F portfolio. Sitting at the No. 2 spot is Jeffrey Tannenbaum of Fir Tree, with a $15.7 million position; 0.4% of its 13F portfolio is allocated to the company. Some other hedge funds with similar optimism include Michael A. Price and Amos Meron’s Empyrean Capital Partners, Glenn Russell Dubin’s Highbridge Capital Management and Eric Edidin and Josh Lobel’s Archer Capital Management.

As one would reasonably expect, specific money managers were breaking ground themselves. AQR Capital Management, managed by Cliff Asness, established the most valuable position in Global Eagle Acquisition Corp (NASDAQ:ENT). AQR Capital Management had 16.7 million invested in the company at the end of the quarter. Glenn Russell Dubin’s Highbridge Capital Management also made a $10 million investment in the stock during the quarter. The other funds with brand new ENT positions are Cliff Asness’s AQR Capital Management, Glenn Russell Dubin’s Highbridge Capital Management, and Louis Bacon’s Moore Global Investments.

What do corporate executives and insiders think about Global Eagle Acquisition Corp (NASDAQ:ENT)?

Insider purchases made by high-level executives is at its handiest when the company we’re looking at has seen transactions within the past six months. Over the latest 180-day time frame, Global Eagle Acquisition Corp (NASDAQ:ENT) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Global Eagle Acquisition Corp (NASDAQ:ENT). These stocks are Hyde Park Acquisition Corp II (NASDAQ:HPAC), New Mountain Finance Corp. (NYSE:NMFC), Lydall, Inc. (NYSE:LDL), Harbinger Group Inc (NYSE:HRG), and Steel Partners Holdings LP (NYSE:SPLP). All of these stocks are in the conglomerates industry and their market caps are closest to ENT’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!